Phone: 800-242-2787 ext. 6448 Specialties Genetics, Molecular Genetics, Molecular Testing for Inherited Disorders Education Master's Degree – Medical Genetics, University of Wisconsin-Madison Certification/Affiliations American Board of Genetic Counseling National Society of Genetic…

2022-03-07

ARUP’s next generation sequencing (NGS) tests are now faster and more precise thanks to the launch of Rio, a new world-class bioinformatics pipeline and analytics platform.

2021-11-18

PacBio and ARUP Laboratories announced they are collaborating on a study intended to evaluate whether the solve rate for rare disease cases can be increased.

2021-11-02

ARUP Consult released new and updated resources on genetic cardiovascular disease, the effects of common anticoagulants on coagulation testing, laboratory testing for primary sclerosing cholangitis.

2021-01-11

Utah added screening for GAMT deficiency to its NBS panel in 2015, becoming the first state to do so. It is now one of only three states to screen for the condition.

2020-12-30

In December 2020, Utah’s Newborn Screening Program identified the first patient with guanidinoacetate methyltransferase (GAMT) deficiency solely through newborn screening.

Assistant Professor, University of Utah Specialties Human genetics Genomics Structural variation in the human genome Genetics of B-cell ALL Genetics of adult diffuse glioma Education Doctorate Degree—Genetics and Molecular Biology, Watson School of Biological Sciences Fellowship—…

2020-07-20

Karl Voelkerding, MD, FCAP, once imagined practicing medicine as a primary care physician in a rural setting. Instead, Voelkerding would become one the world’s leading experts in NGS.

Assistant Professor, University of Utah School of Medicine Education Doctorate Degree—Genetics, Okayama University Medical Degree—Mansoura University Research Fellowship—Genetics, Boston Children’s Hospital Fellowship—Clinical Molecular Genetics, Icahn School of Medicine at Mount Sinai…

2020-02-20

ARUP Laboratories announced today that the Food and Drug Administration (FDA) has filed ARUP’s premarket approval application (PMA) for an AAV5 total antibody assay.

Subscribe to Genetics